F&P Healthcare updates financial outlook for 2027
By HME News Staff
Updated 8:23 AM CDT, Mon August 24, 2026
AUCKLAND, New Zealand – Fisher & Paykel Healthcare now expects revenue of about $1.24 billion and net profit after tax of about $280 million for the first half of the 2027 financial year, representing about 14% and 24% growth, respectively, compared to the prior-year period. It now expects operating revenue to be about $2.47 billion to $2.57 billion and net profit after tax to be about $525 million to $565 million for the 2027 financial year. “We have had a strong start to our first half, particularly in our Hospital product group, as a result of continued strong demand for our latest range of hardware devices and ongoing change in clinical practice driving consumable sales,” said Lewis Gradon, managing director and CEO. “It is also pleasing to see the progress we are making with our continuous improvement activities and the impact on our gross margin and other operating efficiencies.” The guidance assumes July 31 exchange rates. The network profit after tax guidance incorporates $23 million in U.S. IEEPA tariff refunds.
Comments